All In Biotech

Free tool

FAERS Monitor: Radiogardase (Prussian Blue)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021626 or its brand name (Radiogardase (Prussian Blue), Ferric Hexacyanoferrate(Ii)). Reports on generic versions are filed under their own applications.

Reports

4

Serious

1

25% of reports

Hospitalization

0

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • constipation2
  • altered state of consciousness1
  • bowel movement irregularity1
  • depression1
  • diarrhoea1
  • drug intolerance1
  • hot flush1
  • hypernatraemia1
  • hypokalaemia1
  • influenza like illness1
  • insomnia1
  • malaise1
  • myalgia1
  • seizure1
  • tinnitus1

Reports by year received

View as table
YearReports
20193
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,155 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypernatraemia11055.5193.3263
bowel movement irregularity1686.7125.8171
altered state of consciousness1242.844.560
tinnitus1114.521.028
hypokalaemia1113.920.928
hot flush169.812.817
influenza like illness163.911.715
drug intolerance154.410.013
constipation248.218.152
seizure145.58.310
myalgia130.95.77
depression123.14.25
insomnia119.73.64
malaise112.02.22
diarrhoea18.11.51

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.